Yan Wang, LuLu Zhang, XueZhi Liu, Dong Wang, JianXiong Ma
{"title":"Macrophage immunometabolic reprogramming in inflammatory repair failure in osteonecrosis of the femoral head","authors":"Yan Wang, LuLu Zhang, XueZhi Liu, Dong Wang, JianXiong Ma","doi":"10.1016/j.jot.2026.101212","DOIUrl":"10.1016/j.jot.2026.101212","url":null,"abstract":"<div><div>The classical “vascular occlusion” model does not fully account for osteonecrosis of the femoral head (ONFH). Femoral head collapse may progress despite restored perfusion, and ischemia alone cannot adequately explain steroid-associated ONFH. We propose that ONFH involves disruption of bone-vascular-immune homeostasis, with macrophage immunometabolic reprogramming in response to hypoxic and lipotoxic stress acting as a potential driver of inflammatory repair failure. Among the metabolic mechanisms implicated in ONFH, the strongest disease-specific evidence supports roles for hypoxia, oxidative stress, disordered lipid metabolism, macrophage imbalance, and ferroptosis-associated injury. By contrast, macrophage-specific glycolytic reprogramming, remodeling of the tricarboxylic acid (TCA) cycle, epigenetic fixation, osteomac dysfunction, and cuproptosis remain less well established. Regulated cell death pathways, particularly ferroptosis and pyroptosis, may exacerbate local tissue injury by releasing damage-associated molecular patterns (DAMPs) and inflammatory mediators that disrupt type H vessel-osteogenesis coupling and shift repair toward fibrosis. Establishing causal relationships rather than correlative associations will require lineage-tracing experiments, spatial validation, metabolic flux analyses, and genetic loss-of-function studies in ONFH models.</div></div><div><h3>The translational potential of this article</h3><div>Viewing ONFH as an immunometabolic disorder identifies experimentally tractable targets beyond conventional anti-inflammatory strategies, including SLC7A11/GPX4-dependent ferroptosis defense, NLRP3 inflammasome signaling, and HIF-1α-associated macrophage metabolic adaptation. Extracellular vesicle- or biomaterial-based delivery systems designed for prolonged local retention should currently be considered experimental platforms for assessing lesion-specific target engagement in early-stage ONFH. Their clinical relevance must be established through ONFH-specific studies evaluating efficacy, safety, biodistribution, manufacturability, and long-term structural outcomes.</div></div>","PeriodicalId":16636,"journal":{"name":"Journal of Orthopaedic Translation","volume":"60 ","pages":"Article 101212"},"PeriodicalIF":9.8,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148935448","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"hUC-MSCs transplantation promotes neurological recovery by ameliorating spinal cord injury and hippocampal synaptic remodeling in female mice","authors":"Boya Huang, Jiahao Ren, Xinjie Liu, Mi Zhou, Yilin Pang, Zemin Cao, Xiaofeng Lin, Xiang Gao, Baoyou Fan, Yan Hao, Shen Liu, Hui Shen, Guangzhi Ning, Xue Yao, Shiqing Feng","doi":"10.1016/j.jot.2026.101214","DOIUrl":"10.1016/j.jot.2026.101214","url":null,"abstract":"<div><h3>Introduction</h3><div>Spinal cord injury (SCI) induces not only local spinal cord pathology but also distal brain dysfunction, causing multi-dimensional impairments in motor, emotional, and cognitive functions. Human umbilical cord mesenchymal stem cells (hUC-MSCs) transplantation has emerged as a promising therapeutic strategy for SCI, but whether it concurrently improves pathological alterations in both the spinal cord and brain remains unclear.</div></div><div><h3>Methods</h3><div>After establishing a mouse model of spinal cord contusion, hUC-MSCs were transplanted intrathecally starting 7 d post-injury and administered weekly for 4 wk. This study evaluated the effectiveness of hUC-MSCs transplantation in promoting neurological functional recovery in female mice with SCI through multi-dimensional behavioral tests. In addition, histopathological staining, immunofluorescence staining, and western blotting were performed to evaluate pathological changes in the spinal cord and hippocampus after hUC-MSCs transplantation.</div></div><div><h3>Results</h3><div>hUC-MSCs transplantation significantly improved hindlimb locomotor function and alleviated anxiety-like and depression-like behaviors, as well as long-term memory deficits in female mice with SCI. At the spinal cord level, hUC-MSCs increased IL-10 expression, reduced glial activation, and promoted axonal regeneration. In the hippocampus, hUC-MSCs alleviated neuroinflammation and region-specific abnormalities in synaptic remodeling and microglial synaptic pruning.</div></div><div><h3>Conclusion</h3><div>This study demonstrated that hUC-MSCs transplantation concurrently improved pathological alterations in both the spinal cord and hippocampus after SCI, providing experimental evidence for comprehensive neurorestoration following SCI.</div></div><div><h3>Translational potential</h3><div>This preclinical study demonstrated that subacute sequential hUC-MSCs transplantation is a promising therapeutic strategy for SCI. By improving both motor, emotional, and cognitive outcomes, it supports the concept of “brain-spinal co-repair” and provides a rationale for optimizing cell transplantation regimens to facilitate the clinical translation of hUC-MSC-based therapies for SCI.</div></div>","PeriodicalId":16636,"journal":{"name":"Journal of Orthopaedic Translation","volume":"60 ","pages":"Article 101214"},"PeriodicalIF":9.8,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148958470","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Chinese expert consensus on the clinical application of stromal vascular fraction combined with bone marrow flushing for osteonecrosis of the femoral head","authors":"Xin Wang, Junming Zhang, Liming Cheng, Jiang Peng","doi":"10.1016/j.jot.2026.101192","DOIUrl":"10.1016/j.jot.2026.101192","url":null,"abstract":"<div><div>Osteonecrosis of the femoral head (ONFH) is a common orthopedic disease that leads to severe dysfunction of the hip joint in young and middle-aged patients. Its core pathological mechanism lies in the interruption of blood supply to the femoral head and an imbalance in bone repair capacity. Traditional hip-preserving treatment methods face many limitations in promoting effective repair of the necrotic area. With the rapid development of regenerative medicine, stromal vascular fraction (SVF) therapy, due to its rich content of various repair cells and growth factors, provides a highly promising new strategy for promoting angiogenesis and bone tissue regeneration in the necrotic area. Bone marrow flushing, as a key auxiliary means to optimize the local repair microenvironment, can further enhance the therapeutic effect when combined with SVF. This expert consensus aims to systematically review the current evidence-based medical evidence and clinical practice experience of SVF combined with bone marrow flushing in the treatment of ONFH, and to clarify the core norms and operational standards for its clinical application. The article will focus on in-depth elaboration of the indications and contraindications for SVF therapy, the standardized preparation and quality control system of cell preparations, key technical points of clinical minimally invasive surgical operations (including bone marrow flushing standards), multi-dimensional efficacy evaluation methods, and prevention and management strategies for potential complications. It is intended to provide clinicians with a set of standardized and scientific practical guidelines, ultimately promoting the safe, standardized, and effective application of SVF combined with bone marrow flushing technology in the field of ONFH treatment.</div></div>","PeriodicalId":16636,"journal":{"name":"Journal of Orthopaedic Translation","volume":"60 ","pages":"Article 101192"},"PeriodicalIF":9.8,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13636308/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149111108","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Exercise alleviates age-related osteoarthritis associated with PGC-1α activation to suppress chondrocyte senescence and aberrant glycolysis","authors":"Yuting Cao, An Lao, Shijie Zhu, Fangchun Jin, Zhou Sha, Yu Zhuang, Huilu Zhan, Liao Wang, Huiwu Li, Kaili Lin, Rui Zhu","doi":"10.1016/j.jot.2026.101213","DOIUrl":"10.1016/j.jot.2026.101213","url":null,"abstract":"<div><h3>Background</h3><div>Age-related osteoarthritis (OA) is a leading global disability cause. Exercise is recommended as first-line therapy but poorly tolerated by elderly patients. This study elucidated the mechanism of low-intensity exercise in OA and develop a targeted exercise-mimetic nanotherapy.</div></div><div><h3>Methods</h3><div>The effects of low-intensity swimming exercise on age-related OA were investigated using aged mouse models. A senescence-targeted nanoparticle system (NP-B2M) was fabricated via a double-emulsion solvent evaporation method combined with EDC/NHS conjugation. The mechanisms underlying exercise and PGC-1α–mediated metabolic reprogramming were explored using transcriptomic sequencing, glycolysis analysis, RT-qPCR, and Western blotting in IL-1β–induced senescent ATDC5 chondrocytes. The therapeutic efficacy of intra-articular delivery of NP-B2M was systematically evaluated using micro-CT, histological staining, and immunohistochemistry in aged mice.</div></div><div><h3>Results</h3><div>Low-intensity swimming attenuated OA by suppressing chondrocyte senescence and pathological glycolysis via activating PGC-1α, effects that were recapitulated by ZLN005. NP-B2M enabled targeted intra-articular drug release and showed superior efficacy over free ZLN005.</div></div><div><h3>Conclusion</h3><div>This study demonstrates that low-intensity exercise alleviates age-related OA via PGC-1α–mediated metabolic reprogramming. NP-B2M provides a biocompatible, precisely targeted, long-acting platform that mimics exercise benefits, offering promising translational potential as a precision therapeutic strategy for immobile elderly OA patients.</div></div><div><h3>The translational potential of this article</h3><div>In this study, we developed NP-B2M, a PLGA-based nanoplatform, achieves prolonged joint retention and enhanced efficacy versus free drug, representing a promising targeted approach for OA patients with limited mobility.</div></div>","PeriodicalId":16636,"journal":{"name":"Journal of Orthopaedic Translation","volume":"60 ","pages":"Article 101213"},"PeriodicalIF":9.8,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149044075","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Preclinical evaluation of a fully threaded biodegradable magnesium alloy headless compression screw for enhanced fixation in small bones","authors":"Hiroshi Noguchi, Kotaro Hanada, Ryunosuke Watanabe, Yasukazu Totoki, Yohei Tomaru, Akira Ikumi, Akira Kitagawa, Sakiko Orui, Lulu Zhang, Hajime Mishima","doi":"10.1016/j.jot.2026.101201","DOIUrl":"10.1016/j.jot.2026.101201","url":null,"abstract":"<div><h3>Background</h3><div>Biodegradable magnesium (Mg) alloys have attracted attention as alternatives to conventional metallic implants; however, their clinical applicability to fully threaded headless compression (HC) screws has been scarcely investigated.</div></div><div><h3>Methods</h3><div>In this study, a fully threaded biodegradable Mg alloy HC screw was developed, and its mechanical performance, biological safety, and in vivo degradation behavior were systematically evaluated. Mechanical properties were assessed according to ASTM standards and compared with clinically used titanium (Ti) alloy and poly-L-lactic acid/hydroxyapatite (PLLA/HA) screws. Biological safety was evaluated in accordance with ISO 10993 and in compliance with Good Laboratory Practice. In vivo degradation behavior was investigated using a rabbit distal femoral condyle model.</div></div><div><h3>Results</h3><div>The Mg alloy HC screw demonstrated superior torsional strength compared with PLLA/HA screws and comparable insertion performance, along with enhanced fixation strength, compared with Ti alloy screws. No cytotoxicity, sensitization, or intracutaneous reactivity was observed. Although transient gas cavity formation was observed during the early implantation period, it progressively diminished over time and did not adversely affect bone formation or implant stability.</div></div><div><h3>Conclusion</h3><div>These findings indicate that the developed Mg alloy HC screw exhibits favorable mechanical performance, biocompatibility, and in vivo degradation. This study provides preclinical evidence supporting its potential clinical translation, particularly in eliminating the need for secondary implant removal surgery.</div></div><div><h3>The translational potential of this article</h3><div>This article focuses on the preclinical evaluation of a fully threaded Mg-alloy HC screw developed to improve fixation performance for small bone fractures. The results of this study have significant clinical potential for the fully threaded design of biodegradable Mg alloy implants in fracture treatment.</div></div>","PeriodicalId":16636,"journal":{"name":"Journal of Orthopaedic Translation","volume":"60 ","pages":"Article 101201"},"PeriodicalIF":9.8,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148854622","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Jiangbo Nie, Yang Zhou, Xinsheng Xie, Jinfa Wu, Weilai Tong, Zhiguo Shu, Shijiang Wang, Jiaming Liu, Feng Yang, Zhili Liu
{"title":"PLPP1 inhibits Wnt/β-catenin signaling via enhancing Caveolin-1/β-catenin interaction and is negatively regulated by c-Myc in osteosarcoma","authors":"Jiangbo Nie, Yang Zhou, Xinsheng Xie, Jinfa Wu, Weilai Tong, Zhiguo Shu, Shijiang Wang, Jiaming Liu, Feng Yang, Zhili Liu","doi":"10.1016/j.jot.2026.101202","DOIUrl":"10.1016/j.jot.2026.101202","url":null,"abstract":"<div><h3>Background</h3><div>Osteosarcoma (OS) is the most common primary malignant bone tumor in adolescents, characterized by rapid progression and poor prognosis. The molecular mechanisms underlying OS malignancy remain incompletely understood. Phospholipid phosphatase 1 (PLPP1) has recently been implicated in cancer biology, yet its role in OS is largely unknown.</div></div><div><h3>Methods</h3><div>RNA sequence data from TARGET-OS and GEO cohorts were downloaded and analyzed for assessing the relationship between PLPP1 expression levels and the OS prognosis. PLPP1 expression levels in OS cells and samples were detected using qRT-PCR, WB and immunohistochemistry. The effects of PLPP1 on proliferation, migration, invasion and chemosensitivity of OS cells were evaluated by up- or down-regulated PLLP1 expression. In <em>vivo</em> subcutaneous and tail-vein xenograft models were used to examine tumor growth and metastasis. Then, transcriptome profiling, luciferase reporter assays, co-immunoprecipitation, immunofluorescence and ChIP-PCR were conducted to elucidate the molecular mechanisms.</div></div><div><h3>Results</h3><div>PLPP1 was markedly down-regulated in OS tissues and cell lines. And low expression level of PLPP1 was correlated with poor prognosis, advanced clinical stage and metastasis. Functionally, PLPP1 overexpression inhibited OS cell proliferation, migration, invasion, and enhanced chemotherapy-induced apoptosis; conversely, silencing PLPP1 produced the opposite effects. In <em>vivo</em>, PLPP1 overexpression suppressed tumor growth and lung metastasis. Mechanistically, overexpression of PLPP1 impaired strength of Wnt/β-catenin signaling without altering β-catenin abundance, but instead inhibited β-catenin nuclear import by enhancing Caveolin-1/β-catenin interaction. Furthermore, PLPP1 was transcriptionally repressed by c-Myc, which directly bound to the PLPP1 promoter. Rescue experiments confirmed that c-Myc promoted OS malignancy by repressing PLPP1, thereby activating Wnt/β-catenin signaling.</div></div><div><h3>Conclusions</h3><div>This study identified PLPP1 as a prognostic suppressor in OS that inhibited β-catenin nuclear import through enhancing Caveolin-1/β-catenin interaction and was transcriptionally repressed by c-Myc. Targeting the c-Myc/PLPP1/β-catenin axis might represent a promising therapeutic strategy for OS.</div></div><div><h3>The translational potential of this article</h3><div>This study revealed the potential of PLPP1 as a novel prognostic biomarker of OS, and suggested its potential for therapeutic applications by specifically activating PLPP1 expression using small-molecule activators.</div></div>","PeriodicalId":16636,"journal":{"name":"Journal of Orthopaedic Translation","volume":"60 ","pages":"Article 101202"},"PeriodicalIF":9.8,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149141032","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Biomimetic nanodelivery of antagomiR-155-5p ameliorates wear particle-induced osteolysis by dual regulation of Gas6/Axl-mediated macrophage inflammation","authors":"Taihe Liu, Sipeng Lin, Chenhao Pan, Yifan Yu, Haopeng Sun, Junxi Chen, Muyun Tan, Changchuan Li, Shixun Li, Siyuan Tan, Gang Zeng, Haoxian Liu, Wingcheuk Ko, Jing Xu, Yujun Sun, Phei Er Saw, Yue Ding","doi":"10.1016/j.jot.2026.101198","DOIUrl":"10.1016/j.jot.2026.101198","url":null,"abstract":"<div><h3>Background</h3><div>Aseptic loosening (AL) is the primary cause of prosthesis failure after total joint replacement, which is triggered by wear particle-induced macrophage activation, excessive inflammatory factor secretion and subsequent periprosthetic osteolysis. MicroRNAs (miRNAs) act as key regulators of this pathological cascade, yet the specific functional miRNAs and their precise regulatory mechanisms remain incompletely clarified.</div></div><div><h3>Methods</h3><div>mRNA-seq and miRNA-seq were performed in titanium particle (TiPs)-stimulated macrophages to screen osteolysis-associated miRNAs, with expression validation conducted in clinical periprosthetic osteolytic tissues. In vitro functional and mechanistic assays were used to verify the miR-155-5p/Gas6/Axl regulatory axis, and a mouse calvarial osteolysis model was applied for in vivo validation. Macrophage membrane-camouflaged PLGA-PEI nanoparticles loaded with antagomir-155-5p (Anta-155@MNPs) were constructed, and their local therapeutic efficacy was evaluated in murine osteolysis models.</div></div><div><h3>Results</h3><div>miR-155-5p was significantly upregulated in both TiPs-stimulated macrophages and clinical periprosthetic osteolytic tissues. Functionally, miR-155-5p promoted Stat1/p65 phosphorylation, proinflammatory cytokine production and M1 macrophage polarization by inhibiting the Gas6/Axl pathway via dual mechanisms: Mafb-mediated Gas6 transcriptional repression and Adam10-dependent Axl cleavage inhibition. In vivo, this axis exacerbated TiPs-induced calvarial osteolysis, while local Anta-155@MNPs administration markedly mitigated bone resorption and tissue inflammation.</div></div><div><h3>Conclusion</h3><div>miR-155-5p drives TiPs-induced periprosthetic osteolysis via the Gas6/Axl signaling pathway, and targeted inhibition of miR-155-5p is a promising strategy to prevent artificial joint AL.</div></div><div><h3>The translational potential of this article</h3><div>This study identifies the miR-155-5p/Gas6/Axl axis as a novel therapeutic target for AL, and the targeted Anta-155@MNPs delivery system provides a feasible preclinical strategy for clinical translation to treat wear particle-induced osteolysis.</div></div>","PeriodicalId":16636,"journal":{"name":"Journal of Orthopaedic Translation","volume":"60 ","pages":"Article 101198"},"PeriodicalIF":9.8,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148935198","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Yongquan Wang, Zoran Pletikosa, Peilin Chen, Jiayue Li, Ziming Chen, Cameron Bright, Sharon Chu, Alex O'Beirne, David Brogan, Brendan F. Kennedy, Harry Hoyen, Haotian Li, Daohui Li, Clair Lee, Lingqiang Chen, Rui Ruan, Minghao Zheng
{"title":"Collagen epineurial substitute-assisted neurorrhaphy is superior to conventional end-to-end neurorrhaphy in a rat model of peripheral nerve injury","authors":"Yongquan Wang, Zoran Pletikosa, Peilin Chen, Jiayue Li, Ziming Chen, Cameron Bright, Sharon Chu, Alex O'Beirne, David Brogan, Brendan F. Kennedy, Harry Hoyen, Haotian Li, Daohui Li, Clair Lee, Lingqiang Chen, Rui Ruan, Minghao Zheng","doi":"10.1016/j.jot.2026.101197","DOIUrl":"10.1016/j.jot.2026.101197","url":null,"abstract":"<div><h3>Background</h3><div>Peripheral nerve injuries (PNIs) are common and may result in profound and persistent functional deficits. Although end-to-end neurorrhaphy remains the gold standard for nerve repair, clinical outcomes are frequently suboptimal. This study aimed to validate a novel surgical method using a collagen epineurial substitute (CES) to minimize the number of sutures and reduce nerve tension at the coaptation site.</div></div><div><h3>Methods</h3><div>Finite element analysis (FEA) was performed to simulate stress distribution and guide suture configuration. Sprague–Dawley (SD) rats underwent sciatic nerve transection and were allocated into six groups: control; end-to-end neurorrhaphy using 1, 3, or 6 epineurial sutures; or epineurial substitute-assisted repair with one or no coaptation-site sutures. Mechanical stability was validated by tensile testing, while the Sciatic Functional Index (SFI) and gastrocnemius muscle weight were used as screening assessments to evaluate functional recovery. Histological outcomes, including vascularization and cellular alignment at the transection site, were also assessed. A further comparison between two representative groups, based on the equivalent mechanical stability was performed using behavioural tests for sensory recovery and electrophysiological testing for motor recovery to precisely track functional outcomes, together with Osmium staining for myelin and Silver staining for nerve fibres, to further investigate nerve tissue regeneration associated with microenvironmental changes.</div></div><div><h3>Results</h3><div>To test if CES-assisted repair can stabilize the mechanical strength and reduce nerve tension at the coaptation site, we first used FEA and demonstrated that, under physiological tension (2%), CES-assisted nerve coaptation redistributed mechanical stress along the covering of nerve segment. In contrast, conventional neurorrhaphy showed the concentrated tension of nerve at the coaptation. These computational findings were further supported by biomechanical testing in the rat model. The failure load of constructs repaired with three coaptation-site sutures was not significantly different from that of epineurial substitute-assisted constructs without coaptation-site sutures (p = 0.0635) and was significantly lower than that of CES-assisted constructs incorporating a single coaptation-site suture (p = 0.0022). This optimised mechanical environment offered by CES-assisted neurorrhaphy led to a 63–82% increase in parallel direction ratios relative to suture-only repairs, thereby promoting superior cellular alignment at the nerve transection site, enhancing epineurial and intraneural vascularization and reducing suture-related inflammation. In contrast, excessive suturing impaired early regenerative responses, whereas the epineurial substitute approach facilitated a tension-free microenvironment conducive to axonal regeneration and tissue integration. Repair of transected nerves","PeriodicalId":16636,"journal":{"name":"Journal of Orthopaedic Translation","volume":"60 ","pages":"Article 101197"},"PeriodicalIF":9.8,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149044135","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Dewei Zhao, Weidan Wang, Ye Li, Frank Witte, Qing Lu, Weirong Li, Tianwei Zhang, Xiuzhi Zhang, Ling Qin
{"title":"Current status and future prospects of biodegradable magnesium-based implants developed for orthopaedic applications","authors":"Dewei Zhao, Weidan Wang, Ye Li, Frank Witte, Qing Lu, Weirong Li, Tianwei Zhang, Xiuzhi Zhang, Ling Qin","doi":"10.1016/j.jot.2026.101200","DOIUrl":"10.1016/j.jot.2026.101200","url":null,"abstract":"<div><div>Biodegradable magnesium-based implants are the most clinically translated biodegradable metallic biomaterials in orthopaedics, owing to their favorable biocompatibility, bone-matched mechanics, and bioactive degradation behaviour. Through Mg<sup>2+</sup> release, these implants may support osteogenesis, angiogenesis, and immunomodulation while avoiding permanent implant retention. However, their broader adoption remains constrained by degradation/healing mismatch, gas-associated issues, site-specific mechanical limitations, and insufficient long-term safety evidence. This review summarises the current status of biodegradable magnesium-based orthopaedic implants from a translational perspective by integrating biological mechanisms, preclinical animal models, clinical progress, long-term and regulation-related challenges. We particularly highlight the dual biological effects of Mg-based degradation, the translational relevance of disease-oriented small- and large-animal models, and emerging clinical evidence. By linking mechanistic insight with preclinical and clinical evidence, this review highlights the major opportunities and unresolved barriers that will shape the next stage of clinical translation in this field.</div><div>The translational potential of this article.</div><div>This review summarises biodegradable magnesium-based orthopaedic implants from a translational perspective, linking biological mechanisms, preclinical animal models, clinical evidence, long-term safety, and regulation-related considerations. By identifying key barriers to clinical adoption and highlighting indication-oriented evaluation strategies, it provides a practical reference for the future development, assessment, and translation of magnesium-based implants in orthopaedics.</div></div>","PeriodicalId":16636,"journal":{"name":"Journal of Orthopaedic Translation","volume":"60 ","pages":"Article 101200"},"PeriodicalIF":9.8,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149141034","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Exosomes target liver TREM-1 to break the systemic inflammatory cascade and improve spinal cord injury outcomes","authors":"Chengfang Luo, Han Zheng, Xuexiang Wang, Wenxiang Li, Yiming Gao, Zhongze Yuan, Yongfu Lou, Xiaohong Kong, Caorui Lin, Fanshuo Zeng, Ning Ran, Shiqing Feng","doi":"10.1016/j.jot.2026.101221","DOIUrl":"10.1016/j.jot.2026.101221","url":null,"abstract":"<div><h3>Background</h3><div>Spinal cord injury (SCI) is a catastrophic neurological disorder characterized by irreversible functional deficits and the absence of effective clinical therapies. Increasing evidence suggests liver inflammation has emerged as a critical contributor to the exacerbation of secondary injury by amplifying systemic inflammatory responses and hindering neurological recovery following SCI, suggesting that mitigating hepatic inflammation may alleviate disease progression. Recently, exosomes have gained attention as promising therapeutic agents due to their ability to mediate intercellular communication and deliver bioactive molecules. Whether exosome-based interventions can modulate liver inflammation and improve SCI outcomes remains to be elucidated.</div></div><div><h3>Methods</h3><div>Functional recovery was assessed using BMS, gait analysis and inclined plane test. Histological and molecular analyses were performed to evaluate spinal cord pathology. Downstream inflammatory signaling pathways were further analyzed through immunohistology staining, flow cytometry and q-RT-PCR to elucidate the cascade involved in liver-mediated secondary injury. Exosomal cargo was characterized by proteomics and western blotting with a focus on heat shock protein 70 (HSP70). Competitive inhibition experiment was used to determine the interaction between exosome-delivered HSP70 and Triggering Receptor Expressed on Myeloid cells-1 (TREM-1) on hepatic macrophages <em>in vitro</em>.</div></div><div><h3>Results</h3><div>Exosomes from different sources significantly improve functional recovery following SCI, as evidenced by enhanced locomotor performance and reduced tissue damage. Importantly, exosome treatment markedly attenuated liver inflammation, characterized by reduced macrophage activation and decreased expression of pro-inflammatory cytokines. Mechanistically, we found that exosomal HSP70 interacts with TREM-1 on hepatic macrophages. This interaction competitively inhibits the binding of HMGB1, a key damage-associated molecular pattern that is persistently elevated after SCI. By blocking the HMGB1-TREM-1 axis, exosomal HSP70 effectively suppresses downstream inflammatory signaling and mitigates the amplification of systemic inflammation originating from the liver.</div></div><div><h3>Conclusion</h3><div>This study uncovers a previously unrecognized systemic mechanism by which exosomes promote recovery after SCI through the modulation of liver inflammation. By targeting the HMGB1-TREM-1 signaling pathway in hepatic macrophages via exosomal HSP70 delivery, exosomes effectively suppress the inflammatory cascade that contributes to secondary injury.</div></div><div><h3>The translational potential of this article</h3><div>Targeting systemic inflammation, particularly liver-mediated immune responses, may complement existing neuroprotective strategies and improve therapeutic outcomes. These findings pave the way for future preclinical and clinic","PeriodicalId":16636,"journal":{"name":"Journal of Orthopaedic Translation","volume":"60 ","pages":"Article 101221"},"PeriodicalIF":9.8,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148958569","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}